{
  "trial_id": "NCT02862548",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, body mass index (BMI), baseline serum estimated glomerular filtration rate (eGFR), baseline HBV DNA levels, liver transplant type (primary or secondary), time since liver transplant, use of TDF alone or in combination with other antivirals, baseline alanine aminotransferase (ALT) levels, baseline international normalized ratio (INR), baseline albumin levels, baseline direct bilirubin levels, baseline platelet count, co-infection status (HIV or HCV), history of malignancy, cardiovascular disease status, pulmonary disease status, neurological disease status, alcohol or substance abuse history, pregnancy status, use of investigational agents.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "HBV Deoxy Ribonucleic Acid (DNA)",
          "baseline HBV DNA levels"
        ],
        [
          "eGFR by CKD-EPI Creatinine",
          "baseline serum estimated glomerular filtration rate (eGFR)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "liver transplant type (primary or secondary)",
        "time since liver transplant",
        "use of TDF alone or in combination with other antivirals",
        "baseline alanine aminotransferase (ALT) levels",
        "baseline international normalized ratio (INR)",
        "baseline albumin levels",
        "baseline direct bilirubin levels",
        "baseline platelet count",
        "co-infection status (HIV or HCV)",
        "history of malignancy",
        "cardiovascular disease status",
        "pulmonary disease status",
        "neurological disease status",
        "alcohol or substance abuse history",
        "pregnancy status",
        "use of investigational agents"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Chronic Hepatitis B Virus Infection, Type of Transplant (Primary or Secondary), Time Since Liver Transplant, Baseline eGFR, Baseline HBV DNA Levels, Concomitant Medications, Baseline ALT, Baseline INR, Baseline Albumin, Baseline Direct Bilirubin, Baseline Platelet Count,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "HBV Deoxy Ribonucleic Acid (DNA)",
          "Baseline HBV DNA Levels"
        ],
        [
          "eGFR by CKD-EPI Creatinine",
          "Baseline eGFR"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Duration of Chronic Hepatitis B Virus Infection",
        "Type of Transplant (Primary or Secondary)",
        "Time Since Liver Transplant",
        "Concomitant Medications",
        "Baseline ALT",
        "Baseline INR",
        "Baseline Albumin",
        "Baseline Direct Bilirubin",
        "Baseline Platelet Count"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Liver Transplant Type, Time Since Liver Transplant, eGFR_CKD-EPI, HBV DNA, ALT, INR, Albumin, Direct Bilirubin, Platelet Count, History of Hepatocellular Carcinoma, History of De Novo or Recurrent Hepatocellular Carcinoma Post-Transplant.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "HBV Deoxy Ribonucleic Acid (DNA)",
          "HBV DNA"
        ],
        [
          "eGFR by CKD-EPI Creatinine",
          "eGFR_CKD-EPI"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Liver Transplant Type",
        "Time Since Liver Transplant",
        "ALT",
        "INR",
        "Albumin",
        "Direct Bilirubin",
        "Platelet Count",
        "History of Hepatocellular Carcinoma",
        "History of De Novo or Recurrent Hepatocellular Carcinoma Post-Transplant."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), liver transplant type (primary or secondary, deceased or living donor), time since liver transplant, HBV DNA level at screening, eGFR_CKD-EPI at screening, ALT level at screening, INR at screening, albumin level at screening, direct bilirubin level at screening, platelet count at screening, history of HCC, history of decompensated cirrhosis, history of cardiovascular disease, history of pulmonary disease, history of neurological disease, use of antivirals prior to screening, use of immunosuppressive therapy prior to screening.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "HBV Deoxy Ribonucleic Acid (DNA)",
          "HBV DNA level at screening"
        ],
        [
          "eGFR by CKD-EPI Creatinine",
          "eGFR_CKD-EPI at screening"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "body mass index (BMI)",
        "liver transplant type (primary or secondary, deceased or living donor)",
        "time since liver transplant",
        "ALT level at screening",
        "INR at screening",
        "albumin level at screening",
        "direct bilirubin level at screening",
        "platelet count at screening",
        "history of HCC",
        "history of decompensated cirrhosis",
        "history of cardiovascular disease",
        "history of pulmonary disease",
        "history of neurological disease",
        "use of antivirals prior to screening",
        "use of immunosuppressive therapy prior to screening"
      ]
    }
  }
}